{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:21:39Z","timestamp":1795022499426,"version":"4.10.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:p>\n                    The aim of this study was to investigate the relationship between serum ultrasensitive C-reactive protein (hs-CRP) levels and stroke incidence and to assess its potential role in decision-making for thrombolytic therapy in stroke. Given that hs-CRP is a well-recognized marker of inflammation, its association with cardiovascular disease makes this area of research significant. Using NHANES data (3144 participants, including 239 stroke cases), we analyzed associations between inflammatory markers and stroke via bivariate correlation, restricted cubic spline regression, and neural network modeling. Model performance was evaluated by receiver operating characteristic curves and confusion matrices. Stroke patients exhibited significantly higher hs-CRP (3.1\u2009mg\/L) and ferritin (133 \u03bcg\/L) but lower granulocyte-to-lymphocyte ratio (GLR) (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05). Hs-CRP\u2005&gt;2\u2009mg\/L markedly increased stroke risk (HR\u2005&gt;1.0,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05). Correlation analysis confirmed hs-CRP (\n                    <jats:italic toggle=\"yes\">R<\/jats:italic>\n                    \u2005=\u20050.050) and ferritin (\n                    <jats:italic toggle=\"yes\">R<\/jats:italic>\n                    \u2005=\u20050.052) as positive risk factors, while GLR was protective (r=\u22120.054). The neural network model prioritized ferritin (importance\u2005=\u20050.257) and hs-CRP (0.246), achieving 88.7% accuracy. Additional risk factors included depression (OR\u2005=\u20052.12), smoking, and advanced age. Elevated hs-CRP (\u22652\u2009mg\/L) and ferritin are robust predictors of stroke risk and may indicate adverse outcomes post-thrombolysis. Combined with GLR, these markers support personalized thrombolytic therapy decisions. Further validation in prospective cohorts is warranted.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045405","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:01:32Z","timestamp":1761332492000},"page":"e45405","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning prediction of thrombolysis efficacy using hs-CRP and inflammatory markers in stroke"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7437-744X","authenticated-orcid":false,"given":"Yanli","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Neurology V, Baoding First Central Hospital. No. 320, Baoding City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology V, Baoding First Central Hospital. No. 320, Baoding City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology V, Baoding First Central Hospital. No. 320, Baoding City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology V, Baoding First Central Hospital. No. 320, Baoding City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology V, Baoding First Central Hospital. No. 320, Baoding City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology V, Baoding First Central Hospital. No. 320, Baoding City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology V, Baoding First Central Hospital. No. 320, Baoding City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"e51171","DOI":"10.2196\/51171","article-title":"Scalable approach to consumer wearable postmarket surveillance: development and validation study.","volume":"12","author":"Yoo","year":"2024","journal-title":"JMIR Med Inform"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"693894","DOI":"10.3389\/fneur.2022.693894","article-title":"Prevalence and risk factors of high-risk population for stroke: a population-based cross-sectional survey in Southwestern China.","volume":"13","author":"Yi","year":"2022","journal-title":"Front Neurol"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"710744","DOI":"10.3389\/fneur.2022.710744","article-title":"Age-period-cohort analysis of long trend of mortality for stroke and subtypes attributed to high SBP in Chinese adults.","volume":"13","author":"Ma","year":"2022","journal-title":"Front Neurol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1381612826666200717090334","article-title":"High sensitivity C-reactive Protein (hsCRP) and its implications in cardiovascular outcomes.","volume":"27","author":"Denegri","year":"2021","journal-title":"Curr Pharm Des"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/STROKEAHA.120.029232","article-title":"Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review.","volume":"52","author":"Montellano","year":"2021","journal-title":"Stroke"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1161\/STROKEAHA.121.034388","article-title":"Inflammation and stroke risk: a new target for prevention.","volume":"52","author":"Kelly","year":"2021","journal-title":"Stroke"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"e0183706","DOI":"10.1371\/journal.pone.0183706","article-title":"Elevated neutrophil to lymphocyte ratio and ischemic stroke risk in generally healthy adults.","volume":"12","author":"Suh","year":"2017","journal-title":"PLoS One"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1001\/jama.2021.20750","article-title":"Effect of a diagnostic strategy using an elevated and age-adjusted d-dimer threshold on thromboembolic events in emergency department patients with suspected pulmonary embolism: a randomized clinical trial.","volume":"326","author":"Freund","year":"2021","journal-title":"JAMA"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/00033197211004392","article-title":"Relationship between C-reactive protein to albumin ratio and coronary collateral circulation in patients with stable coronary artery disease.","volume":"72","author":"Kelesoglu","year":"2021","journal-title":"Angiology"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"591714","DOI":"10.3389\/fcvm.2021.591714","article-title":"C-reactive protein apheresis as anti-inflammatory therapy in acute myocardial infarction: results of the CAMI-1 study.","volume":"8","author":"Ries","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/clc.23749","article-title":"Admission high-sensitivity C-reactive protein levels improve the Grace risk score prediction on in-hospital outcomes in acute myocardial infarction patients.","volume":"45","author":"Lin","year":"2022","journal-title":"Clin Cardiol"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"e0250101","DOI":"10.1371\/journal.pone.0250101","article-title":"Monocyte distribution width compared with C-reactive protein and procalcitonin for early sepsis detection in the emergency department.","volume":"16","author":"Woo","year":"2021","journal-title":"PLoS One"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3390\/molecules24112062","article-title":"The multiple faces of C-reactive protein-physiological and pathophysiological implications in cardiovascular disease.","volume":"24","author":"Boncler","year":"2019","journal-title":"Molecules"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"BSR20181135","DOI":"10.1042\/BSR20181135","article-title":"C-reactive protein for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis.","volume":"39","author":"Yu","year":"2019","journal-title":"Biosci Rep"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.21037\/atm-21-710","article-title":"Neutrophil to lymphocyte ratio and adverse clinical outcomes in patients with ischemic stroke.","volume":"9","author":"Quan","year":"2021","journal-title":"Ann Transl Med"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCRESAHA.121.319994","article-title":"Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke.","volume":"130","author":"Endres","year":"2022","journal-title":"Circ Res"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/CIA.S233909","article-title":"The role of selected pro-inflammatory cytokines in pathogenesis of ischemic stroke.","volume":"15","author":"Pawluk","year":"2020","journal-title":"Clin Interv Aging"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/medicina56050222","article-title":"Siesta and risk for ischemic stroke: results from a case-control study.","volume":"56","author":"Mohammad","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/ars.2020.8167","article-title":"Non-transferrin-bound iron in the spotlight: novel mechanistic insights into the vasculotoxic and atherosclerotic effect of iron.","volume":"35","author":"Vinchi","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/path.5212","article-title":"Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time-dependent manner during atherothrombosis.","volume":"247","author":"Pertiwi","year":"2019","journal-title":"J Pathol"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"300060519895352","DOI":"10.1177\/0300060519895352","article-title":"Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction.","volume":"48","author":"Sun","year":"2020","journal-title":"J Int Med Res"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijms22020954","article-title":"Impact of SMTP targeting plasminogen and soluble epoxide hydrolase on thrombolysis, inflammation, and ischemic stroke.","volume":"22","author":"Hasumi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/eurheartj\/ehab110","article-title":"The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.","volume":"42","author":"Ceglarek","year":"2021","journal-title":"Eur Heart J"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41582-021-00605-6","article-title":"Pharmacological brain cytoprotection in acute ischaemic stroke \u2013 renewed hope in the reperfusion era.","volume":"18","author":"Fisher","year":"2022","journal-title":"Nat Rev Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:00:54Z","timestamp":1795021254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":24,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045405","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2025-07-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}